by Usha Govindarajulu | Jun 9, 2021 | Biostatistics, Blog, Healthcare, Professor, Usha Govindarajulu

P-values and vaccine efficacy

As the companies continue to re-evaluate vaccine efficacy against new variants, have they discussed p-values? Are they analyzing re-updated data again and again and correcting for inflation of the Type I error rate?? Given the p-value controversy in statistics and the controversy of vaccine efficacy, statisticians have to wonder if these topics have been considered together. Even if this topic is being considered, it is hardly discussed. One can only imagine it must have been very difficult to plan these trials and…

Usha Govindarajulu

Usha Govindarajulu is a writer and biostatistician .

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store